OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2024
(3)
2021
(3)
2023
(2)
2022
(2)
2025
(1)
2019
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
Not available
S-EPMC8284438
|
biostudies-literature
Cite
Flat dose regimen of toripalimab based on model-informed drug development approach.
Not available
S-EPMC9880172
|
biostudies-literature
Cite
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy.
Not available
S-EPMC6601540
|
biostudies-literature
Cite
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.
Not available
S-EPMC11260571
|
biostudies-literature
Cite
Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
Not available
S-EPMC10565143
|
biostudies-literature
Cite
A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants.
Not available
S-EPMC8787029
|
biostudies-literature
Cite
Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia.
Not available
S-EPMC11255649
|
biostudies-literature
Cite
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.
Not available
S-EPMC8517012
|
biostudies-literature
Cite
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
Not available
S-EPMC8078488
|
biostudies-literature
Cite
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Not available
S-EPMC10685882
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets